Home

Alzheimer's Disease

Alzheimer's Disease

Read time: 3 min

Congress highlights

Initial promise of immunotherapeutics targeting amyloid-β strengthens the possibility of early intervention in Alzheimer’s disease

Clinical studies of immunotherapies show initial promise for early intervention in Alzheimer’...

Alzheimer's Disease

Read time: 3 min

Congress highlights

The many faces of tau offer multiple targets for intervention in Alzheimer’s disease

Tau is a complex, multifaceted target, implicated in many mechanisms involved in the pathology of...

Alzheimer's Disease

Read time: 3 min

Congress highlights

It’s in the blood – identification of plasma biomarkers brings hope for screening and early detection of Alzheimer’s disease

The recent discovery and validation of blood biomarkers offers huge potential for the early...

Alzheimer's Disease

Read time: 5 min

Could targeting the brain’s clearance systems be beneficial in Alzheimer’s Disease?

Amyloid-beta (Aβ) accumulation in Alzheimer’s Disease (AD) may, in part, be due to an...

Alzheimer's Disease

Read time: 5 min

Taking a closer look at tau

Our understanding of tau pathology, a critical component of Alzheimer’s Disease development,...

Alzheimer's Disease

Read time: 4 min

New insights into Apolipoprotein E and Alzheimer’s Disease

Apolipoprotein E4 is a major risk factor for Alzheimer’s Disease and is strongly related to...

Alzheimer's Disease

Read time: 6 min

Advances in the early diagnosis of Alzheimer’s Disease

Many challenges exist in a patient’s journey to their diagnosis of Alzheimer’s Disease...

Alzheimer's Disease

Read time: 5 min

Congress highlights

Making the most of Big Data in Alzheimer's Disease

In this symposium, recent trends in data analysis and study design were discussed alongside...

Alzheimer's Disease

Read time: 3 min

Congress highlights

Aging, amyloid and Alzheimer’s Disease

Amyloid-beta (Aβ) burden in cognitively normal older adults increases with age and appears to be...

Alzheimer's Disease

Read time: 4 min

Congress highlights

Person-centered care in dementia: are we there yet?

Interest in psychosocial research in people living with dementia and their caregivers is growing....

Alzheimer's Disease

Read time: 2 min

Congress highlights

Open science to transform research in Alzheimer’s disease

Research into Alzheimer’s disease and related dementias is growing rapidly, but how can this...

Alzheimer's Disease

Read time: 3 min

Congress highlights

Unraveling network dysfunction in Alzheimer’s Disease

Amyloid precursor protein/amyloid-beta and tau appear to act together to cause deficits in synaptic...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country